{"id":10336,"date":"2025-10-20T18:04:48","date_gmt":"2025-10-20T16:04:48","guid":{"rendered":"http:\/\/pepticore-aminos.local\/?post_type=product&p=10336"},"modified":"2026-04-08T07:57:45","modified_gmt":"2026-04-08T05:57:45","slug":"n-acetyl-semax-amidate","status":"publish","type":"product","link":"https:\/\/pepticoreaminos.net\/en\/product\/n-acetyl-semax-amidate\/","title":{"rendered":"N-Acetyl Semax Amidate 10mg"},"content":{"rendered":"
\n
\n

N-Acetyl Semax Amidate<\/h1>\n

Peptide sintetico per la ricerca su neuroprotezione, funzione cognitiva, rigenerazione neuronale e modulazione dell\u2019umore.<\/p>\n<\/header>\n

\n

What Is N-Acetyl Semax Amidate<\/h3>\n

N-Acetyl Semax Amidate<\/strong> is a synthetic peptide<\/strong> derived from a short sequence of the adrenocorticotropic hormone (ACTH)<\/strong>, specifically amino acids 4\u201310. Originally developed in Russia, this compound has been studied for its neuroprotective<\/strong>, neurotrophic<\/strong>, and neuromodulatory<\/strong> properties. In research settings, Semax and its acetylated variants are evaluated for their ability to support cognitive functions<\/strong>, improve memory<\/strong>, and promote neuronal recovery in models of ischemic stroke<\/strong>, dementia<\/strong>, and optic nerve inflammation<\/strong>. It has also shown potential antidepressant<\/strong> and anxiolytic<\/strong> effects, possibly through the regulation of serotonin<\/strong> and dopamine<\/strong> levels in the central nervous system.<\/p>\n<\/article>\n

\n

Mechanism of Action and Biochemical Role<\/h3>\n

Semax acts as an analogue of ACTH but lacks its peripheral hormonal properties, focusing instead on the central nervous system<\/strong>. Experimental studies show that it promotes the transcription of neurotrophic factors such as BDNF (Brain-Derived Neurotrophic Factor)<\/strong> and NGF (Nerve Growth Factor)<\/strong>, which are essential for neurogenesis<\/strong>, synaptogenesis<\/strong>, and neuronal plasticity<\/strong>. The increase in BDNF<\/strong> observed after administration of N-Acetyl Semax<\/strong> suggests an enhanced ability of the brain to adapt to stimuli and injury, supporting processes of learning, memory, and motor recovery.<\/p>\n

In parallel, the peptide helps regulate neuronal redox balance and mitochondrial<\/strong> stability\u2014critical for cell survival during oxidative or ischemic stress\u2014yielding a combined profile of neuroprotection<\/strong>, gene modulation<\/strong>, and metabolic support<\/strong> for neural tissue.<\/p>\n<\/article>\n

\n

Cognitive Effects and Brain Networks<\/h3>\n

Functional magnetic resonance imaging (fMRI<\/strong>) studies have shown that N-Acetyl Semax<\/strong> enhances the activity of the default mode network (DMN)<\/strong>, a group of brain areas more active at rest than during focused tasks. This network contributes to environmental awareness<\/strong>, social attention<\/strong>, and self-reflection<\/strong>. Increased connectivity suggests improved baseline attention and cognitive readiness, enabling faster shifts from rest to focus<\/p>\n

Strengthened communication between regions\u2014particularly the prefrontal cortex<\/strong> and hippocampus<\/strong>\u2014is associated with better problem-solving<\/strong>, memory<\/strong>, and creativity<\/strong>, indicating a potential global enhancement of neural connectivity<\/strong>.<\/p>\n<\/article>\n

\n

N-Acetyl Semax in the Setting of Stroke<\/h3>\n

In the context of stroke<\/strong> and cerebral hypoxia<\/strong>, animal studies indicate that N-Acetyl Semax<\/strong> modifies the expression of numerous genes involved in vascular function<\/strong> and angiogenesis<\/strong>. These changes regulate smooth muscle cell migration, red blood cell formation, and new vessel growth, improving oxygen and nutrient delivery to damaged brain tissue.<\/p>\n

Clinical research conducted in Russia associates Semax administration during post-stroke rehabilitation with faster motor recovery<\/strong> and higher plasma levels of BDNF<\/strong>, suggesting enhanced neuroplasticity<\/strong> and functional reorganization of the brain.<\/p>\n<\/article>\n

\n

Gene Expression and Neurotrophic Factors<\/h3>\n

Research on healthy animal models shows that even a single intranasal dose of N-Acetyl Semax<\/strong> can rapidly influence gene expression in the frontal cortex<\/strong> and hippocampus<\/strong>, regions essential for attention<\/strong>, organization<\/strong>, memory<\/strong>, and learning<\/strong>. Gene activation occurs within 20 minutes of administration and particularly affects NGF<\/strong> and BDNF<\/strong>, reinforcing neuroplasticity<\/strong> and synaptic efficiency.<\/p>\n

findings support the use of Semax as a model to explore molecular mechanisms of learning and memory and strategies to enhance cognitive performance.<\/p>\n<\/article>\n

\n

N-Acetyl Semax Mood Regulation<\/h3>\n

Studies indicate that increased BDNF<\/strong> levels induced by Semax<\/strong> can help regulate mood and stress responses. In models of depression<\/strong>, the peptide normalizes serotonergic<\/strong> and dopaminergic<\/strong> function, suggesting an effect similar or complementary to SSRI antidepressants<\/strong>.<\/p>\n

Unlike SSRIs, which often require weeks to achieve therapeutic results, Semax may act more directly via BDNF<\/strong>-linked neurogenesis<\/strong> and neuronal plasticity<\/strong>, potentially shortening response times\u2014though this remains a preclinical observation.<\/p>\n<\/article>\n

\n

Research Applications and Safety<\/h3>\n

In animal models, N-Acetyl Semax<\/strong> shows good subcutaneous bioavailability<\/strong> and a favorable safety profile<\/strong> with minimal side effects. However, dose translation from mice to humans is not linear, and no clinical use is approved. Current investigations remain within laboratory research<\/strong>, focusing on links between neuroprotection<\/strong>, post-ischemic recovery<\/strong>, and strong>cognitive function<\/strong>. The product is intended exclusively for scientific research<\/strong> and is not approved for human or veterinary use.<\/p>\n<\/article>\n

\n

Sources and Further Reading<\/h3>\n